ロード中...
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel
Dual oral antiplatelet therapy, aspirin plus thienopyridine, has permitted a rapid increase in the use of coronary intervention procedures. Clopidogrel is the thienopyridine of choice for dual antiplatelet therapy in patients treated with percutaneous coronary intervention. However, there are two is...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686264/ https://ncbi.nlm.nih.gov/pubmed/19475783 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|